Introduction Executive Summary Small Cell Lung Cancer: Overview ● Causes ● Mechanism of Action ● Signs and Symptoms ● Diagnosis ● Disease Management Pipeline Therapeutics ● Comparative Analysis Therapeutic Assessment ● Assessment by Product Type ● Assessment by Stage and Product Type ● Assessment by Route of Administration ● Assessment by Stage and Route of Administration ● Assessment by Molecule Type ● Assessment by Stage and Molecule Type Small Cell Lung Cancer – DelveInsight’s Analytical Perspective In-depth Commercial Assessment ● Small Cell Lung Cancer companies’ collaborations, Licensing, Acquisition -Deal Value Trends Small Cell Lung Cancer Collaboration Deals ● Company-Company Collaborations (Licensing / Partnering) Analysis ● Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) ● Comparative Analysis HLX-10: Henlix Biotech ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) ● Comparative Analysis LP002: Taizhou HoudeAoke Biomedical Co., Ltd. ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I/II) ● Comparative Analysis APG-1252: Ascentage Pharma Group Inc. ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Preclinical Stage Products ● Comparative Analysis Drug Name: Company Name ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Inactive Products ● Comparative Analysis Small Cell Lung Cancer Key Companies Small Cell Lung Cancer Key Products Small Cell Lung Cancer- Unmet Needs Small Cell Lung Cancer- Market Drivers and Barriers Small Cell Lung Cancer- Future Perspectives and Conclusion Small Cell Lung Cancer Analyst Views Small Cell Lung Cancer Key Companies Appendix

Table 1 Total Products for Small Cell Lung Cancer Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Henlix Biotech • Genentech • Hoffman-La-Roche • BeiGene • Jiangsu HengRui Medicine Co., Ltd. • AstraZeneca • Bristol-Myers Squibb • Merck Sharp & Dohme • Haihe Biopharma Co., Ltd. • Ipsen • United Therapeutics • Luye pharma Group, Ltd • Taizhou HoudeAoke Biomedical Co., Ltd. • CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Nippon Kayaku Co., Ltd. • Bristol-Myers Squibb • AstraZeneca • Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Boehringer Ingelheim • EpicentRx, Inc. • Eli Lilly and Company • Pfizer • Xencor, Inc. • Ascentage Pharma Group Inc. • Aileron Therapeutics • Celgene Corporation • Harpoon Therapeutics • Novartis Pharmaceuticals • AnewPharma • Abbvie • Sanofi • Sunesis Pharmaceuticals • GalxoSmithKline • Astellas Pharma